V. Romanou

Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

Juan Mauricio Pardo Oviedo, A. Nica, M. Antonelli, 2021, Drugs.

Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.

Juan Mauricio Pardo Oviedo, A. Nica, M. Antonelli, 2022, Intensive care medicine.

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.

Christos G Gogos, K. Arvaniti, G. Daikos, 2020, The Journal of antimicrobial chemotherapy.

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

Juan Mauricio Pardo Oviedo, A. Nica, M. Antonelli, 2019, Intensive Care Medicine.

Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?

I. Vasileiadis, N. Rovina, A. Koutsoukou, 2021, Journal of personalized medicine.

Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum

N. Rovina, A. Koutsoukou, G. Dimopoulos, 2022, Journal of clinical medicine.

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

B. Souweine, A. Nica, P. Póvoa, 2023, Intensive Care Medicine.

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

Juan Mauricio Pardo Oviedo, A. Nica, M. Antonelli, 2019, Intensive care medicine.